Total Payments
$3,210
2024 Payments
$1,003
Companies
40
Transactions
192
Medicare Patients
4,626
Medicare Billing
$332,474
Payment Breakdown by Category
Food & Beverage$3,157 (98.3%)
Education$53.02 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,157 | 183 | 98.3% |
| Education | $53.02 | 9 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $525.23 | 33 | $0 (2024) |
| ABBVIE INC. | $432.61 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $345.70 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $223.41 | 10 | $0 (2024) |
| PFIZER INC. | $184.15 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $135.02 | 7 | $0 (2024) |
| Lilly USA, LLC | $132.99 | 8 | $0 (2024) |
| Amgen Inc. | $107.46 | 7 | $0 (2022) |
| Dexcom, Inc. | $96.46 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $90.78 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,003 | 56 | Novo Nordisk Inc ($219.19) |
| 2023 | $920.94 | 53 | Novo Nordisk Inc ($164.07) |
| 2022 | $309.15 | 18 | GlaxoSmithKline, LLC. ($38.59) |
| 2021 | $327.86 | 25 | AbbVie Inc. ($112.46) |
| 2020 | $377.82 | 23 | Astellas Pharma US Inc ($64.34) |
| 2019 | $96.82 | 3 | Boston Scientific Corporation ($68.49) |
| 2018 | $105.13 | 5 | Amgen Inc. ($37.20) |
| 2017 | $68.90 | 9 | Novo Nordisk Inc ($47.38) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Hepatitis B Vaccine | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Obesity | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Insomnia | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Insomnia | ||||||
| 09/17/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Oncology | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: PAIN | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Obesity | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 964 | 1,292 | $196,928 | $76,803 |
| 2022 | 20 | 1,305 | 1,820 | $232,230 | $75,599 |
| 2021 | 12 | 966 | 1,619 | $230,326 | $77,605 |
| 2020 | 23 | 1,391 | 2,336 | $323,966 | $102,468 |
Total Patients
4,626
Total Services
7,067
Medicare Billing
$332,474
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 443 | $112,079 | $37,400 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $21,331 | $10,265 | 48.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $9,222 | $8,184 | 88.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 73 | $12,994 | $4,739 | 36.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 44 | $7,132 | $3,138 | 44.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 122 | 122 | $6,344 | $3,033 | 47.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,175 | $2,485 | 30.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 132 | 132 | $4,752 | $2,313 | 48.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 94 | 94 | $3,478 | $1,647 | 47.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 47 | $3,619 | $1,371 | 37.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 31 | $2,387 | $904.27 | 37.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 17 | $2,975 | $700.54 | 23.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 20 | 23 | $851.00 | $273.17 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 20 | $940.00 | $188.78 | 20.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 46 | 52 | $364.00 | $114.40 | 31.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 57 | $285.00 | $48.01 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 311 | 536 | $139,991 | $40,676 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 73 | 73 | $20,721 | $9,264 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 145 | $25,672 | $8,387 | 32.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $7,910 | $3,004 | 38.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $5,187 | $2,114 | 40.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 86 | 88 | $2,288 | $1,465 | 64.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 71 | 71 | $3,103 | $1,279 | 41.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 72 | 72 | $3,080 | $1,273 | 41.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 105 | 110 | $3,850 | $1,141 | 29.6% |
About Dr. David Locklear, M.D
Dr. David Locklear, M.D is a Family Medicine healthcare provider based in Maiden, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679535322.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Locklear, M.D has received a total of $3,210 in payments from pharmaceutical and medical device companies, with $1,003 received in 2024. These payments were reported across 192 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,157).
As a Medicare-enrolled provider, Locklear has provided services to 4,626 Medicare beneficiaries, totaling 7,067 services with total Medicare billing of $332,474. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Maiden, NC
- Active Since 04/06/2006
- Last Updated 11/28/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679535322
Products in Payments
- VRAYLAR (Drug) $261.09
- Ozempic (Drug) $228.49
- FARXIGA (Drug) $164.92
- UBRELVY (Drug) $141.01
- TRELEGY ELLIPTA (Drug) $133.10
- Rybelsus (Drug) $123.59
- Dexcom G6 Transmitter (Medical Supply) $96.46
- BREZTRI (Drug) $94.95
- Wegovy (Drug) $92.67
- MOUNJARO (Drug) $72.33
- SPECTRA WAVEWRITER (Device) $68.49
- NURTEC ODT (Drug) $67.32
- JARDIANCE (Drug) $66.19
- MYRBETRIQ (Drug) $64.34
- GEMTESA (Drug) $61.21
- AIRSUPRA (Drug) $57.95
- Kerendia (Drug) $50.96
- SOLIQUA 100/33 (Biological) $50.36
- Heplisav-B (Drug) $48.34
- SYNTHROID (Drug) $48.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Maiden
Dr. Teresa Stump, D.o, D.O
Family Medicine — Payments: $1,591
Family Medicine $1,591
Dr. Jermaine Joefield, M.d, M.D
Family Medicine — Payments: $1,449
Family Medicine $1,449
Anne Olejarz, Do, DO
Family Medicine — Payments: $1,111
Family Medicine $1,111
Andrew Chesson, Md, MD
Family Medicine — Payments: $488.29
Family Medicine $488.29